N-((6-Bromopyridin-3-yl)methyl)cyclopropanamine hydrochloride

Catalog No. :
ACNRBE490
CAS No. :
1353953-53-3
Molecular Formula :
C9H12BrClN2
Molecular Weight :
263.57

IUPAC Name:N-((6-bromopyridin-3-yl)methyl)cyclopropanamine hydrochloride

N-((6-Bromopyridin-3-yl)methyl)cyclopropanamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$259.00Login to see priceInquiryInquiry
1g95%$646.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-((6-Bromopyridin-3-yl)methyl)cyclopropanamine hydrochloride
IUPAC NameN-((6-bromopyridin-3-yl)methyl)cyclopropanamine hydrochloride
MDL No.MFCD19686145
Molecular FormulaC9H12BrClN2
Molecular Weight263.57
SMILESBrC1=CC=C(CNC2CC2)C=N1.[H]Cl
InChI KeyJLHQRXUTTHLMGN-UHFFFAOYSA-N
Synonym(6-BroMo-pyridin-3-ylMethyl)-cyclopropyl-aMine hydrochloride;N-((6-BROMOPYRIDIN-3-YL)METHYL)CYCLOPROPANAMINE HCL
CAS No.1353953-53-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACNRBE490 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0 In Stock
  2. Plus
  3. ACXQTW732 route compound structure diagram
    ACXQTW732149806-06-4 In Stock
  4. Then
  5. ACNRBE490 route product structure diagram
    ACNRBE4901353953-53-3
Inquiry

2. ACNRBE490 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOYCN817 route compound structure diagram
    ACOYCN817101990-45-8 In Stock
  2. Plus
  3. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0 In Stock
  4. Then
  5. ACNRBE490 route product structure diagram
    ACNRBE4901353953-53-3
Inquiry

Comments (0)